Collaborators

At Idera, we believe collaborations are key to advance the science of TLR-targeted therapeutics. Our focus is on development of compounds that are agonists or antagonists of TLRs 7, 8, and 9. We have active collaborations with academic research centers and with major pharmaceutical companies. We have collaborations to explore applications of our technology to respiratory diseases and as vaccine adjuvants and oncology.
 
We are open to opportunities for collaborations that would apply our technology in additional areas of unmet medical needs with partners who bring complementary expertise and experience. If you have an interest in a potential collaboration with Idera, please contact us at: